More Progress on LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment – PR Newswire (press release)
|
More Progress on LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment
PR Newswire (press release) The rapidly emerging immunotherapy approach, known as CAR (chimeric antigen receptor) T–cell immunotherapy, uses genetic engineering to reprogram the patient's own immune T cells to find and kill cancer cells. These engineered T cells persist in the … |
